Verathon recall designated Class I; Zoll debuts pediatric CPR electrodes;

 @FierceMedDev: AspenBio Pharma seeks rebirth as Venaxis, with focus on diagnostics. More | Follow @FierceMedDev

@MarkHFierce: A conservative Washington Post blogger calls out medical device tax "hypocrites" who voted for it, and now oppose it. Story | Follow @MarkHFierce

 @DamianFierce: Between FDA earfuls, analyst warnings and, now, a shareholder lawsuit, St. Jude Medical is having a rough winter. Article | Follow @DamianFierce

> Devicemaker Verathon must now face an FDA class I recall for the company's reusable blades in its GlidScope GVL video laryngoscope. It had previously launched a voluntary recall due to the potential for cracking or breaking. FDA notice

> St. Jude Medical ($STJ) has launched its Ellipse ICD in India. Article

> Maquet Cardiovascular gained the FDA's Circulatory System Devices Panel vote recently, recommending reclassification from Class III to Class II the use of the company's intra-aortic balloon pump for certain indications. Item

> Zoll Medical is rolling out newly-cleared pediatric CPR electrodes that it bills as the first of their kind with a built-in sensor that works with young children up to age 8. Release

> New diagnostics tests for cardiac conditions developed by Abbott ($ABT) and others help reduce the time needed to start treatment for a heart attack, according to a new study, and also may improve the way doctors diagnose heart attacks in women. Release

> Sterling Medical Devices is expanding. That's worth noting because the company designs, develops and tests medical devices, diagnostics and related equipment for clients including Boston Scientific ($BSX), Medtronic ($MDT), Johnson & Johnson ($JNJ) and others. Release

> Some stroke patients appear to benefit from both cerebral angioplasty and stent placement, according to a new study published in the journal Radiology. Release

> Tornado survivor Stephanie Decker will appear on Ellen DeGeneres' syndicated talk show Dec. 13, walking for the first time with new foot and ankle prostheses developed by Orthocare Innovations, a 2012 Fierce 15 company. Release

Biotech News

 @FierceBiotech: Eli Lilly hits the brakes on PhIII program in arthritis after 'unexpected' results. Story | Follow @FierceBiotech

@JohnCFierce: Who releases PhIII results one endpoint at a time? Stock up, but $ONCY PR is weak, manipulative. Count me skeptical. More | Follow @JohnCFierce

@RyanFierce: AZN missed big in Phase IIb for oral arthritis drug after previous mixed results. Should have killed program earlier? Report | Follow @RyanMFierce

> Ex-Genzyme CEO Termeer returns to his roots at biotech Prosensa. News

> The Medicines Co. bags Bristol, buyout deals for $300M. Article

Pharma News

@FiercePharma: KV says it's set to emerge from bankruptcy. News | Follow @FiercePharma

> Pfizer to pay $55 million to clean Wyeth's dirty laundry. Item

> AstraZeneca, Lilly feeling real pain in race for arthritis drugs. News

> FDA risk finding adds fuel to fire around Pfizer's Chantix. Story

Vaccine News

> GSK employs mobile phones to up vaccination rates in Africa. Report

> TB vaccine tested in infants of HIV-positive mothers. News

> IDRI fetches $10M from Gates Foundation for adjuvant research. Story

> GAVI Alliance aims to immunize 30 million girls against HPV. Item

> Global pediatric vaccine market to hit $23B by 2015. Article

Pharma Manufacturing News

> Court OKs drug shortage lawsuit against Hospira. News

> Manufacturing at the heart of Teva's $2B cost-cutting drive. Story

> 6 hospitalized as Novartis manufacturing stumbles again. Article

> Manufacturing at the heart of Teva's $2B cost-cutting drive. More

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.